Informa Stock News

NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Informa TechTarget ("Informa" or the "Company") (NASDAQ:TTGT). Such investors are advise

NEW YORK, NY / ACCESSWIRE / December 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Informa TechTarget ("TechTarget" or the "Company") (NASDAQ:TTGT). Such investors are adv

NEWTON, Mass.--(BUSINESS WIRE)--Creation of Informa TechTarget was confirmed with completed combination of TechTarget with Informa Tech's digital businesses – part of Informa PLC.

AI themed stocks boost equities NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Zephyr , a subsidiary of Informa plc (LSE: INF), and a recognized leader in asset and wealth management software has released i

PSN Top Guns List now available publicly NEW YORK , May 30, 2024 /PRNewswire/ -- Zephyr, a subsidiary of Informa plc (LSE: INF), and a recognized leader in asset and wealth management has released its

Growing Expectations for Rate Cuts Propel Global Markets NEW YORK , March 6, 2024 /PRNewswire/ -- Zephyr, a subsidiary of Informa plc (LSE: INF), and a recognized leader in investment management techn

LONDON, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via IBN -- Informa PLC, a prominent international events, digital services, and academic knowledge group, is thrilled to announce its forthcoming event, Quant

Informa (LON: INF) share price has outperformed the FTSE 100 and FTSE 250 indices this year as its business performance improved. The stock has jumped by ~20% this year while the FTSE 100 index has ri

Informa plc (OTCPK:IFPJF) Q4 2022 Earnings Conference Call March 9, 2023 4:00 AM ET Company Participants Stephen Carter - Group Chief Executive Gareth Wright - Group Finance Director Max Gabriel - IIR

Informa plc's (IFPJF) CEO Stephen Carter on Q4 2021 Results - Earnings Call Transcript

Warburg Pincus LLC has tapped the private credit market to fund its 1.7 billion pound ($2.3 billion) takeover of Informa Plc’s Pharma Intelligence division.

Warburg Pincus acquires Pharma Intelligence from Informa Submitted 11/02/2022 - 9:14am Global growth investor Warburg Pincus has acquired Pharma Intelligence, a provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from Informa, an international B2B markets knowledge services and business intelligence group. Mubadala Investment Company, the Abu Dhabi based investment company, joins Warburg Pincus in the investment. The investors plan to extend the company’s position in the pharmaceutical data and analytics market, investing in the creation of innovative products for its customers. Informa will retain a 15 per cent stake in the company. The acquisition includes Informa’s full portfolio of specialist brands which includes the Citeline suite of products, Trialtrove, Sitetrove, Pharmaprojects and Citeline branded products, as well as Biomedtracker, Clinerion, Datamonitor Healthcare, Pink Sheet, Scrip, Skipta, and TrialScope.

Stock prices in London ended higher on Thursday, shrugging off hot inflation data from the US, with Informa lifting the blue-chip index on an agreed unit sale and share buyback.

Shares in the world''s largest exhibitions group rose as much as 5.4% to their highest level since November 2020 off the back of Thursday''s announcement.

(Reuters) -Britains Informa agreed to sell its pharma intelligence business to New York-based investment fund Warburg Pincus for 1.9 billion pounds ($2.58 billion), the events organiser said on Thursday.